Published in Growth Horm IGF Res on March 02, 2010
The changing face of acromegaly--advances in diagnosis and treatment. Nat Rev Endocrinol (2012) 1.03
Acromegaly: the disease, its impact on patients, and managing the burden of long-term treatment. Int J Gen Med (2013) 0.99
Patient perspectives on the impact of acromegaly: results from individual and group interviews. Patient Prefer Adherence (2014) 0.80
Patient-focussed outcomes in acromegaly. Pituitary (2014) 0.77
Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical Parameters. Front Endocrinol (Lausanne) (2017) 0.75
Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet (1999) 3.41
[Cushing's syndrome. I. New diagnostic developments]. Ned Tijdschr Geneeskd (2006) 2.73
How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol (2009) 2.49
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement. Osteoarthritis Cartilage (2010) 2.24
Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis (2005) 2.23
EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Ann Rheum Dis (2008) 2.15
Patient perspective of hand osteoarthritis in relation to concepts covered by instruments measuring functioning: a qualitative European multicentre study. Ann Rheum Dis (2008) 2.10
Response to interferon alfa-2b in a patient with systemic mastocytosis. N Engl J Med (1992) 1.95
Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus. Diabetologia (2007) 1.94
Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment. Lancet (1987) 1.90
Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways. AIDS (2001) 1.81
Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. Arterioscler Thromb Vasc Biol (2004) 1.79
Inadvertent instillation of Minims eye drops in an ophthalmic casualty department. Acta Ophthalmol Scand (1995) 1.76
Long term high intensity exercise and damage of small joints in rheumatoid arthritis. Ann Rheum Dis (2004) 1.73
Letter: Septicaemia due to porcine streptococci. Lancet (1975) 1.73
Tumour and tumour-like lesions of the patella--a multicentre experience. Eur Radiol (2008) 1.69
Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism (1991) 1.68
Females secrete growth hormone with more process irregularity than males in both humans and rats. Am J Physiol (1996) 1.66
The suprachiasmatic nucleus generates the diurnal changes in plasma leptin levels. Endocrinology (2001) 1.63
Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthritis Cartilage (2012) 1.62
Usefulness of radiography in differentiating enchondroma from central grade 1 chondrosarcoma. AJR Am J Roentgenol (1997) 1.61
The burden of Cushing's disease: clinical and health-related quality of life aspects. Eur J Endocrinol (2012) 1.58
Reduced disorderliness of growth hormone release in biochemically inactive acromegaly after pituitary surgery. Eur J Endocrinol (1998) 1.56
Nora's lesion, a distinct radiological entity? Skeletal Radiol (2006) 1.52
Quality of life is decreased in female patients treated for microprolactinoma. Eur J Endocrinol (2007) 1.52
Prevalence and clinical significance of organ-specific autoantibodies in type 1 diabetes mellitus. Neth J Med (2007) 1.48
Magnetic resonance imaging of the shoulder in patients with rheumatoid arthritis. Ann Rheum Dis (1990) 1.48
Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial. Eur J Endocrinol (2012) 1.47
Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab (2007) 1.47
[Cushing's syndrome. II. New forms of treatment]. Ned Tijdschr Geneeskd (2006) 1.47
Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol (1995) 1.46
Phacoemulsification versus endocapsular cataract extraction in a unique cohort of patients. Eye (Lond) (1996) 1.46
Progression of acromegalic arthropathy despite long-term biochemical control: a prospective, radiological study. Eur J Endocrinol (2012) 1.43
Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass. J Clin Endocrinol Metab (2001) 1.43
Infusion of long-chain or medium-chain triglycerides inhibits peripheral glucose metabolism in men. JPEN J Parenter Enteral Nutr (1995) 1.42
Lipid profiles in middle-aged men and women after famine exposure during gestation: the Dutch Hunger Winter Families Study. Am J Clin Nutr (2009) 1.42
Anencephaly in the Netherlands: a remarkable decline. Lancet (1983) 1.41
[Increased frequency of icterus in parenterally fed patients after a change of lipid emulsion]. Ned Tijdschr Geneeskd (1999) 1.40
[Transsphenoidal resection of pituitary adenomas: long-term results from the Leiden University Medical Center]. Ned Tijdschr Geneeskd (2008) 1.40
Evidence for familial aggregation of hand, hip, and spine but not knee osteoarthritis in siblings with multiple joint involvement: the GARP study. Ann Rheum Dis (2004) 1.39
[Carboplatin in the treatment of ovarian carcinoma; as effective and less toxic in comparison with cisplatin]. Ned Tijdschr Geneeskd (1991) 1.38
[Acne vulgaris: endocrine aspects]. Ned Tijdschr Geneeskd (2006) 1.38
Epi- and metaphyseal changes in children caused by administration of bisphosphonates. Radiology (1992) 1.37
Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol (2013) 1.36
Cushing's syndrome complicated by multiple opportunistic infections. J Endocrinol Invest (1998) 1.35
Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab (2005) 1.35
PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update (2011) 1.35
Enteropathogenicity markers in Escherichia coli isolated from infants with acute diarrhoea and healthy controls in Rio de Janeiro, Brazil. J Med Microbiol (1998) 1.34
Palliative pamidronate treatment in patients with bone metastases from breast cancer. J Clin Oncol (1993) 1.32
Association of the Frizzled-related protein gene with symptomatic osteoarthritis at multiple sites. Arthritis Rheum (2005) 1.32
The infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype. Ann Rheum Dis (2011) 1.31
OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritis. Osteoarthritis Cartilage (2009) 1.30
Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol (1991) 1.29
Effects of interferon-alpha (IFN-alpha) administration on leucocytes in healthy humans. Clin Exp Immunol (1997) 1.28
In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake. Diabetes (2001) 1.25
What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis? Ann Rheum Dis (2013) 1.25
What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann Rheum Dis (2013) 1.25
Quality of life in patients after long-term biochemical cure of Cushing's disease. J Clin Endocrinol Metab (2005) 1.22
Radiographic damage of large joints in long-term rheumatoid arthritis and its relation to function. Rheumatology (Oxford) (2000) 1.21
Comparative analysis of risk factors for pathological fracture with femoral metastases. J Bone Joint Surg Br (2004) 1.21
EXT-related pathways are not involved in the pathogenesis of dysplasia epiphysealis hemimelica and metachondromatosis. J Pathol (2006) 1.20
Hormone pulsatility discrimination via coarse and short time sampling. Am J Physiol (1999) 1.20
Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab (1990) 1.19
Clusters of biochemical markers are associated with radiographic subtypes of osteoarthritis (OA) in subject with familial OA at multiple sites. The GARP study. Osteoarthritis Cartilage (2006) 1.18
Autoimmunity in Addison's disease. Neth J Med (2002) 1.17
Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene. J Clin Endocrinol Metab (2007) 1.17
Prevalence, extension and characteristics of fluid-fluid levels in bone and soft tissue tumors. Eur Radiol (2006) 1.15
Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis. Clin Endocrinol (Oxf) (2004) 1.15
Limitations in daily activities are the major determinant of reduced health-related quality of life in patients with hand osteoarthritis. Ann Rheum Dis (2010) 1.15
New treatment modalities in advanced thyroid cancer. Ann Oncol (2011) 1.14
Retroperitoneal extraskeletal osteosarcoma. J Clin Pathol (2001) 1.14
Aortic stiffness is associated with cardiac function and cerebral small vessel disease in patients with type 1 diabetes mellitus: assessment by magnetic resonance imaging. Eur Radiol (2009) 1.14
Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions. Int J Endocrinol (2012) 1.14
Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab (2007) 1.13